In:
Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 42, No. 2 ( 2024-01-10), p. 140-145
Abstract:
Adjuvant HIPEC (30 min oxaliplatin) did not improve survival in patients with T4 or perforated colon cancer.
Type of Medium:
Online Resource
ISSN:
0732-183X
,
1527-7755
DOI:
10.1200/JCO.22.02644
Language:
English
Publisher:
American Society of Clinical Oncology (ASCO)
Publication Date:
2024
detail.hit.zdb_id:
2005181-5
detail.hit.zdb_id:
604914-X
Permalink